Delivery Order SPE2DB20D1004-SPE2DB25FNJLV
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,530.36, is for the delivery of medical supplies including 4567265421 ! IYUZEH 0.005% EYE DROP 5S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November...
- The Defense Logistics Agency (DLA) awarded a $2,408.92 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 0.5% lubricant eye drops. The order has a completion date of December 5, 2023. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products to federal agencies, including the Department of Defense and Department of Veterans Affairs. This order is part of Amerisourcebergen's larger...
- This firm fixed-price delivery order, valued at $1,404.70, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of 0.5% lubricant eye drops in 30-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,502.40 firm fixed-price contract is for the delivery of "4566789779 ! IYUZEH 0.005% EYE DROP 5S", a pharmaceutical product. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen is a for-profit organization and a significant vendor for federal healthcare programs,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,189.06 firm-fixed-price delivery order is for the supply of MIEBO 100% Eye Drop 3ML, a medical product, with a completion date of December 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,677.37 firm-fixed-price delivery order is for the supply of 0.5% eye drop lubricant in 30-count packages. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This is a $1,047.98 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for 4567829218 ! VEVYE 0.1% EYE DROP 2ML, which is a medical product used to treat eye conditions. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,516.76 firm fixed-price delivery order is for the supply of "4564617693 ! MIEBO 100% EYE DROP 3ML", with a completion date of May 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $4,577.85 issued by the Defense Logistics Agency (DLA). It covers the procurement of 0.1% eye drop medication, 2ml size, with a completion date of January 6, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary contracting vehicle for...
- The Defense Logistics Agency (DLA) awarded a $9,971.22 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of loteprednol etabonate 0.5% eye drops. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJLVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,222.87 to AmerisourceBergen Drug Corp for the supply of IYUZEH 0.005% eye drop medication. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical medical commodities to support military healthcare programs worldwide through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains on a competitive basis. This particular delivery order for ophthalmic medication reflects the company's role as a key vendor in supporting Defense Health Agency and broader military medical supply needs through flexible contract vehicles designed to ensure consistent access to essential pharmaceutical products for federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/18/25 |